Rubicon Genomics Adds New Distributors Globally For Its DNA Library Preparation Kits
--New Agreements Add Local Distributor Contacts and Know How for Rubicon's Library Prep Kits In Asia, Eastern Europe and North America--
--To Learn More About Rubicon's Innovative Products, Visit Hall A3-Booth 325 at Analytica 2014--
ANN ARBOR, Mich., March 31, 2014 /PRNewswire/ -- Rubicon Genomics, Inc., today announced that it has partnered with additional distributors globally to expand availability of its DNA library preparation products, including its ThruPLEX®-FD Prep Kits and PicoPLEX™ DNA-seq Kits for use with Illumina® next-generation sequencing (NGS) systems. The new distributors include GenoMax Technologies for Singapore and Malaysia, BioChemMack for Russia, Ukraine, Belarus and Kazakhstan and D-Mark Biosciences for Canada.
James Koziarz, PhD, CEO of Rubicon Genomics, commented, "The advantages of our new DNA library preparation kits for use with Illumina NGS systems are illustrated by the fact that our ThruPLEX-FD Prep Kit has been cited in four Nature publications in the past six months alone. As we shift our focus to these kits designed for use with NGS platforms, we are expanding our sales channels by adding complementary distributors around the globe. Researchers will now have easier access to our technology, which provides new capabilities and efficiencies for NGS sequencing in a variety of applications."
ThruPLEX-FD Prep Kits for Illumina NGS platforms streamline library preparation for fragmented DNA/cDNA and reduce sample input amounts to picogram levels. ThruPLEX-FD's patented technology delivers a highly efficient and user-friendly process that takes place in a single tube in less than two hours, improves ligation efficiency and reduces clean-up steps. ThruPLEX-FD provides consistent and reliable results for applications including DNA-seq, RNA-seq and ChIP-seq, and is especially useful for clinical samples such as plasma and FFPE.
PicoPLEX WGA Kit and the new PicoPLEX DNA-seq Kits amplify DNA from a single cell to yield a highly consistent and reproducible library. The product has been used by leaders in the IVF market for pre-implantation genetic screening of embryos to identify aneuploidy and copy number variation on microarrays, and now on Illumina NGS platforms. PicoPLEX's patented technology is optimized for amplification of single copy genomic DNA with input concentrations of less than six picograms. The easy-to-use single tube protocol reduces handling errors and background and dramatically improves time to results.
For more information on Rubicon's products, visit Booth 325 in Hall A3 at Analytica 2014.
Analytica 2014, the 24th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and the Analytica Conference, will be held in Munich, Germany from April 1-4, 2014. For more information visit www.analytica-world.com/en/events/30246/analytica-2014.html
More information on Rubicon's distributors can be found at: http://rubicongenomics.com/how-to-buy/distributors/.
About Rubicon Genomics
Rubicon Genomics, Inc. is a leader in the development and commercialization of innovative sample-specific nucleic acid library preparation products used in research and clinical testing on NGS, microarray and q-PCR platforms. The company creates efficient molecular biology tools for genetic, epigenetic and expression analysis of difficult samples to facilitate gene-based research, drug development and diagnostics. Privately-held Rubicon is located in Ann Arbor, Michigan. For more information, visit rubicongenomics.com.
SOURCE Rubicon Genomics, Inc.